✦ LIBER ✦

467 Different KRAS Mutations Confer Different Sensitivity to Cisplatin in Non Small Cell Lung Cancer

✍ Scribed by Marabese, M.; Caiola, E.; Rusconi, P.; Piva, S.; Garassino, M.; Farina, G.; Broggini, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Geographical differences in non-small ce

✍ Fong, K.M.; Zimmerman, P.V.; Smith, P.J. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Impact of TP53 and KRAS mutations on cis

✍ X. Ma; E. Brambilla; J.C. Soria; A. Dunant; A.L. Vataire; P. Hainaut; the IALT-B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Increased Sensitivity to Cisplatin in No

✍ Andriani, F.; Perego, P.; Carenini, N.; Sozzi, G.; Roz, L. 📂 Article 📅 2006 🏛 Neoplasia Press 🌐 English ⚖ 307 KB

Human non-small cell lung cancer (NSCLC)

✍ C. Mahoney; B. Choudhury; H. Davies; G. Bignell; M. Stratton; A. Futreal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

PTEN mutations and relationship to EGFR,

✍ Jin, Guang; Kim, Min Jung; Jeon, Hyo-Sung; Choi, Jin Eun; Kim, Dong Sun; Lee, Eu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 245 KB

MKP1/CL100 controls tumor growth and sen

✍ Chattopadhyay, S; Machado-Pinilla, R; Manguan-García, C; Belda-Iniesta, C; Morat 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 278 KB